Annual report pursuant to Section 13 and 15(d)

CORPORATE REORGANIZATION AND EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Narrative) (Details)

v3.10.0.1
CORPORATE REORGANIZATION AND EXERCISE OF CALL OPTIONS OF CURECELL AND ATVIO (Narrative) (Details) - USD ($)
$ in Thousands
12 Months Ended
Nov. 30, 2018
Nov. 30, 2017
Revenues $ 18,655 $ 10,089
Atvio and CureCell [Member]    
Debt contributed 2,300  
Business Combination, Step Acquisition, Equity Interest in Acquiree, Remeasurement Gain 4,500  
Revenues $ 1,100  
CureCell [Member]    
Equity Method Investment, Ownership Percentage 94.12%  
Stock Issued During Period, Shares, Acquisitions 202,846  
Other intangible assets $ 3,933  
Total consideration transferred 4,790  
CureCell [Member] | Customer Relationships [Member]    
Other intangible assets $ 859  
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 10 years  
CureCell [Member] | Know-How [Member]    
Other intangible assets $ 3,074  
Acquired Finite-lived Intangible Assets, Weighted Average Useful Life 12 years  
Atvio [Member]    
Stock Issued During Period, Shares, Acquisitions 83,965  
Total consideration transferred $ 890